LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $8.21.

Several brokerages have recently commented on LFST. Cowen lowered their price objective on LifeStance Health Group from $10.00 to $8.00 and set an "outperform" rating on the stock in a research report on Monday, November 14th. Cowen decreased their target price on LifeStance Health Group from $10.00 to $8.00 and set an "outperform" rating on the stock in a research report on Monday, November 14th. Morgan Stanley upgraded LifeStance Health Group from an "equal weight" rating to an "overweight" rating and set a $8.00 target price on the stock in a research report on Friday, January 6th. The Goldman Sachs Group decreased their target price on LifeStance Health Group from $9.00 to $8.00 and set a "neutral" rating on the stock in a research report on Tuesday, November 15th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a $7.25 target price on shares of LifeStance Health Group in a research report on Monday, November 7th.

LifeStance Health Group Price Performance

Shares of LifeStance Health Group stock opened at $5.24 on Tuesday. The stock's 50-day simple moving average is $5.10 and its 200-day simple moving average is $6.36. LifeStance Health Group has a 52 week low of $4.22 and a 52 week high of $11.25. The company has a market capitalization of $1.97 billion, a price-to-earnings ratio of -6.55 and a beta of 0.61. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.14.

Institutional Investors Weigh In On LifeStance Health Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. OLD National Bancorp IN bought a new position in shares of LifeStance Health Group during the fourth quarter valued at approximately $49,000. Dynamic Advisor Solutions LLC bought a new position in shares of LifeStance Health Group during the fourth quarter valued at approximately $56,000. Ameritas Investment Partners Inc. grew its stake in shares of LifeStance Health Group by 56.6% during the first quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company's stock valued at $56,000 after buying an additional 2,016 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in shares of LifeStance Health Group during the second quarter valued at approximately $63,000. Finally, Price T Rowe Associates Inc. MD bought a new position in shares of LifeStance Health Group during the third quarter valued at approximately $75,000. 76.49% of the stock is currently owned by hedge funds and other institutional investors.

About LifeStance Health Group

(Get Rating)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

See Also

• Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
• Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
• Can Cummins Power To A New High?
• How to Find Penny Stocks to Invest and Trade
• ONSemi Is Marching Higher On Great Results
• What Tyson Foods Q1 Means For Staples Stocks

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.